In vitro pharmacokinetic study of the noval anticancer agent E707: red blood cell and plasma protein binding in human blood

H.J.G.D. van den Bongard; D. Pluim; R.C.A.M. Waardenburg; M. Ravic; J.H. Beijnen; J.H.M. Schellens

In vitro pharmacokinetic study of the noval anticancer agent E707: red blood cell and plasma protein binding in human blood

H.J.G.D. van den Bongard, D. Pluim, R.C.A.M. Waardenburg, M. Ravic, J.H. Beijnen, J.H.M. Schellens

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	405-410
Number of pages	6
Journal	Anti-Cancer Drugs
Volume	14
Publication status	Published - 2003

Keywords

Genetics
Farmacie/Biofarmaceutische wetenschappen (FARM)
Farmacie(FARM)
Biochemistry
Biomedische technologie en medicijnen
Analytical chemistry

Cite this

@article{59a57496169b41179140a76287b7e397,

title = "In vitro pharmacokinetic study of the noval anticancer agent E707: red blood cell and plasma protein binding in human blood",

keywords = "Genetics, Farmacie/Biofarmaceutische wetenschappen (FARM), Farmacie(FARM), Biochemistry, Biomedische technologie en medicijnen, Analytical chemistry",

author = "{van den Bongard}, H.J.G.D. and D. Pluim and R.C.A.M. Waardenburg and M. Ravic and J.H. Beijnen and J.H.M. Schellens",

year = "2003",

language = "Undefined/Unknown",

volume = "14",

pages = "405--410",

journal = "Anti-Cancer Drugs",

issn = "0959-4973",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - In vitro pharmacokinetic study of the noval anticancer agent E707: red blood cell and plasma protein binding in human blood

AU - van den Bongard, H.J.G.D.

AU - Pluim, D.

AU - Waardenburg, R.C.A.M.

AU - Ravic, M.

AU - Beijnen, J.H.

AU - Schellens, J.H.M.

PY - 2003

Y1 - 2003

KW - Genetics

KW - Farmacie/Biofarmaceutische wetenschappen (FARM)

KW - Farmacie(FARM)

KW - Biochemistry

KW - Biomedische technologie en medicijnen

KW - Analytical chemistry

M3 - Article

SN - 0959-4973

VL - 14

SP - 405

EP - 410

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

ER -